Cooley-Led Allogene Raises $324M After IPO Prices High
California-based clinical-stage biotechnology company Allogene Therapeutics Inc. started trading on the Nasdaq Global Select Market on Thursday after the Cooley LLP-led company priced its $324 million initial public offering at the high...To view the full article, register now.
Already a subscriber? Click here to view full article